Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Mar. 25, 2012	Mar. 27, 2011
Cash and cash equivalents at beginning of year	$ 27,490	$ 42,691
Operating activities:
Net (loss) income including non-controlling interest	(221)	11,575
Adjustments to reconcile net (loss) income including non-controlling interest to net cash provided by (used in) operating activities:
Equity in earnings of unconsolidated affiliates	(14,166)	(11,887)
Dividends received from unconsolidated affiliates	4,150	4,319
Depreciation and amortization expense	20,384	20,300
Net loss on sale of assets	212	242
Loss on extinguishment of debt	462	3,337
Non-cash compensation expense, net	2,070	1,128
Loss on previously held equity interest	3,656
Deferred income taxes	(505)	(63)
Other	27	157
Changes in assets and liabilities, excluding effects of foreign currency adjustments:
Receivables, net	(4,009)	(11,533)
Inventories	16,784	(22,882)
Other current assets and income taxes receivable	(859)	361
Accounts payable and accrued expenses	(1,574)	3,742
Income taxes payable	843	(209)
Net cash provided by (used in) operating activities	27,254	(1,413)
Investing activities:
Capital expenditures	(5,329)	(17,334)
Investments in unconsolidated affiliates	(360)	(707)
Acquisition, net of cash acquired	(356)
Return of capital from unconsolidated affiliate		500
Proceeds from sale of assets	224	189
Proceeds from return of split dollar life insurance premiums	14	3,241
Net cash used in investing activities	(5,807)	(14,111)
Financing activities:
Payments of notes payable	(10,288)	(47,588)
Payments on revolving credit facility	(95,200)	(105,325)
Proceeds from borrowings on revolving credit facility	95,600	143,125
Proceeds from stock option exercises	71	118
Purchase and retirement of Company stock		(2)
Debt financing fees	(194)	(825)
Contributions from non-controlling interest	320
Other	(319)	(364)
Net cash used in financing activities	(10,010)	(10,861)
Effect of exchange rate changes on cash and cash equivalents	(3,107)	2,836
Net increase (decrease) in cash and cash equivalents	8,330	(23,549)
Cash and cash equivalents at end of period	$ 35,820	$ 19,142